The in silico prediction of human-specific metabolites from hepatotoxic drugs.
about
In silico toxicology models and databases as FDA Critical Path Initiative toolkits.Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities.Chemoinformatics and chemical genomics: potential utility of in silico methods.Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
P2860
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@en
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@nl
type
label
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@en
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@nl
prefLabel
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@en
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@nl
P1476
The in silico prediction of human-specific metabolites from hepatotoxic drugs.
@en
P2093
Anthony Long
Luis G Valerio
P304
P356
10.2174/157016310793180567
P577
2010-09-01T00:00:00Z